Argent Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Argent Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-364	Closed	-$34K	–	139
2021 Q1	$34K	Buy	+364	New	+$36.9K	0.02%	133
2020 Q4	–	Sell	-364	Closed	-$31K	–	164
2020 Q3	$31K	Buy	+364	New	+$42.4K	0.02%	142

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Argent Advisors's VBIV Position: Q2 2021 in Review

Argent Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2021, closing a stake of 364 shares — an estimated $34K sold.

Argent Advisors first reported a position in VBIV in Q3 2020 and held it in 2 quarters. The position peaked at $34K in Q1 2021. 134 funds tracked by Wall St. Rank hold VBIV as of Q2 2021.

Argent Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2021 after selling out during the quarter.
Argent Advisors sold 364 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2021, an estimated $34K.
Argent Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 2 quarters.
Argent Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $34K in Q1 2021.
134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2021.

Based on Argent Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.